Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method

Human Gene Therapy

Volumn 16, Issue 3, 2005, Pages 361-371

  Arad, Uri ^a   Zeira, Evelyn ^a   El Latif, Mahmoud Abd ^a   Mukherjee, Santanu ^a   Mitchell, Leslie ^a   Pappo, Orit ^a   Galun, Eithan ^a   Oppenheim, Ariella ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS T ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CELL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HEPATITIS; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; SIMIAN VIRUS 40; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ALANINE TRANSAMINASE; ANIMALS; ANTIBODIES; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PRIMERS; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; LUCIFERASES; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 16344373721     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.361     Document Type: Article

References (30)

1. ARAD, U., BEN-NUN-SHAUL, O., EL-LATIF, M.A., NISSIM, O., and OPPENHEIM, A. (2002). A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants. Virology 304, 155-159.
2. ARAD, U., AXELROD J., BEN-NUN-SHAUL, O., OPPENHEIM, A., and GALUN, E. (2004). Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors. J. Hepatol. 40, 520-526.
3. 2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle. J. Hematother. Stem Cell Res. 11, 817-828.
4. CORDELIER, P., CALAROTA, S., and STARYER, D. (2003). Transduction of primary human macrophages and dendritic cells by recombinant SV40 vectors [abstract]. Mol. Ther. 7, S111.
5. GINZINGER, D.G. (2002). Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp. Hematol. 30, 503-512.
6. GOLDSTEIN, H., PETTOELLO-MANTOVANI, M., ANDERSON, C.M., CORDELIER, P., POMERANTZ, R.J., and STRAYER, D.S. (2002). Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue. J. Infect. Dis. 185, 1425-1430.
7. HOLLOWAY, P.W. (1973). A simple procedure for removal of Triton X-100 from protein samples. Anal. Biochem. 53, 304-308.
8. HONIGMAN, A., ZEIRA, E., GHANA, P., ABRAMOVITZ, R., TAVOR, E., BAR, I., ZILBERMAN, Y., RABINOVSKY, R., GAZIT, D., JOSEPH, A., PANET, A., SHAI, E., PALMON, A., LASTER, M., and GALUN, E. (2001). Imaging transgene expression in live animals. Mol. Ther. 4, 239-249.
9. JAFAR, S., RODRIGUEZ-BARRADAS, M., GRAHAM, D.Y., and BUTEL, J.S. (1998). Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J. Med. Virol. 54, 276-284.
10. KAFRI, T., BLOMER, U., PETERSON, D.A., GAGE, F.H., and VERMA, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
11. KIMCHI-SARFATY, C., BEN-NUN-SHAUL, O., RUND, D., OPPENHEIM, A., and GOTTESMAN, M.M. (2002). In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer. Hum. Gene Ther. 13, 299-310.
12. KIMCHI-SARFATY, C., ARORA, M., SANDALON, Z., OPPENHEIM, A., and GOTTESMAN, M.M. (2003a). High cloning capacity of in vitro packaged sv40 vectors with no SV40 virus sequences. Hum. Gene Ther. 14, 167-177.
13. KIMCHI-SARFATY, C., GARFIELD, S., VIEIRA, W., ALEXANDER, N., OPPENHEIM, A., and GOTTESMAN, M. (2003b). Efficient gene transfer using an SV40 in vitro packaging system [abstract]. Mol. Ther. 7, S472.
14. KONDO, R., FEITELSON, M.A., and STRAYER, D.S. (1998). Use of SV40 to immunize against hepatitis B surface antigen: Implications for the use of SV40 for gene transduction and its use as an immunizing agent. Gene Ther. 5, 575-582.
15. LAVON, I., GOLDBERG, I., AMIT, S., LANDSMAN, L., JUNG, S., TSUBERI, B.Z., BARSHACK, I., KOPOLOVIC, J., GALUN, E., BUJARD, H., and BEN-NERIAH, Y. (2000). High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat. Med. 6, 573-577.
16. LIU, F., SONG, Y., and LIU, D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266.
17. MURUVE, D.A., BARNES, M.J., STILLMAN, I.E., and LIBERMANN, T.A. (1999). Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10, 965-976.
18. NAKAI, H., MONTINI, E., FUESS, S., STORM, T.A., GROMPE, M., and KAY, M.A. (2003). AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34, 297-302.
19. ROSSMANITH, W., CHABICOVSKY, M., HERKNER, K., and SCHULTE-HERMANN, R. (2002). Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. DNA Cell Biol. 21, 847-853.
20. RUND, D., DAGAN, M., DALYOT-HERMAN, N., KIMCHI-SARFATY, C., SCHOENLEIN, P.V., GOTTESMAN, M.M., and OPPENHEIM, A. (1998). Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions. Hum. Gene Ther. 9, 649-657.
21. SANDALON, Z., and OPPENHEIM, A. (1997). Self-assembly and protein-protein interactions between the SV40 capsid proteins produced in insect cells. Virology 237, 414-421.
22. SANDALON, Z., DALYOT-HERMAN, N., OPPENHEIM, A.B., and OPPENHEIM, A. (1997). In vitro assembly of SV40 virions and pseudovirions: Vector development for gene therapy. Hum. Gene Ther. 8, 843-849.
23. SAUTER, B., PARASHAR, B., CHOWDHURY, N., KADAKOL, A., ILAN, Y., SINGH, H., MILANO, J., STRAYER, D., and CHOWDHURY, J. (2000). A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in Gunn rats. Gastroenterology 119, 1348-1357.
24. STRAYER, D.S., and MILANO, J. (1996). SV40 mediates stable gene transfer in vivo. Gene Ther. 3, 581-587.
25. STRAYER, D.S., POMERANTZ, R.J., YU, M., ROSENZWEIG, M., BOUHAMDAN, M., YURASOV, S., JOHNSON, R.P., and GOLDSTEIN, H. (2000). Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors. Gene Ther. 7, 886-895.
26. STRAYER, D., BRANCO, F., ZERN, M.A., YAM, P., CALAROTA, S.A., NICHOLS, C.N., ZAIA, J.A., ROSSI, J., LI, H., PARASHAR, B., GHOSH, S., and CHOWDHURY, J.R. (2002). Durability of transgene expression and vector integration: Recombinant SV40-derived gene therapy vectors. Mol. Ther. 6, 227-237.
27. VERA, M., ASEGUINOLAZA, G., RODRIGUEZ, C., MARTINEZ, L., BERRAONDO, P., RAZQUIN, N., STRAYER, D., PRIETO, J., and FORTES, P. (2003). Use of SV40 recombinant viruses as vectors for gene therapy [abstract]. Mol. Ther. 7, S365.
28. WICKHAM, T.J. (2003). Ligand-directed targeting of genes to the site of disease. Nat. Med. 9, 135-139.
29. ZERN, M.A., OZAKI, I., DUAN, L., POMERANTZ, R., LIU, S.L., and STRAYER, D.S. (1999). A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Gene Ther. 6, 114-120.
30. ZHANG, G., BUDKER, V., and WOLFF, J.A. (1999). High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735-1737.